Development of Heat or Cold, Hydrolytic Changes, and Development of Poisonous Substances

Chemical Incompatibility: Development of Heat or Cold, Hydrolytic Changes, and Development of Poisonous Substances

Some chemical reactions take place with either the liberation (exothermic reactions) or absorption (endothermic reactions) of considerable amounts of heat.
Prescriptions undergoing such reactions should be carefully studied to determine how these thermal changes impact the activity and safety of the compounds involved.
It is important to note that most chemical reactions which take place spontaneously at room temperature do so with an evolution of heat, indicating that these reactions tend to favor forming more stable products that release energy.
Additionally, systems in nature tend to transition spontaneously to another system of greater stability, although the more stable end product may be inactive as a therapeutic agent.
- In pharmacology, this is crucial as inactive compounds may lead to diminished effectiveness of a medication.
Stable systems can be converted to unstable systems by transfusions of free energy, such as through mixing with other reactants or temperature changes.
Conversely, compounds requiring heat for their formation or maintenance of stability are typically more stable at elevated temperatures, which can impact storage and handling requirements for drugs.

Many substances, particularly those used in pharmacology, tend to undergo hydrolysis in the presence of water.
This process can be hastened by various factors (HHH) such as heat, catalysts, hydrogen ions (H+), and hydroxyl ions (OH-).
Hydrolysis can change the chemical structure of medications, potentially reducing their effectiveness or producing harmful derivatives.
Examples (EAZI):
- Esters and Amides: Compounds often found in pharmaceuticals that are susceptible to hydrolytic degradation, which can lead to the loss of therapeutic effect.
- Zinc and Iron: These metals can undergo hydrolytic changes in aqueous solutions, affecting formulations that rely on their stability for efficacy.

A chemical reaction between two substances may produce products that are significantly more toxic than the original reactants involved, posing a serious risk in both laboratory and clinical settings.
It is essential for chemists and pharmacologists to assess the potential for toxic byproducts when developing or mixing compounds.
Example:
- The reaction between potassium iodide and calomel (mercurous chloride); in the presence of moisture, this reaction leads to the formation of a toxic mercuric salt as one of the products.